Abstract
Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory infections and urinary tract infections. The prevalence of this lethal pathogen increases gradually in the clinical setup where it can grow on artificial surfaces, utilize ethanol as a carbon source. Moreover it resists desiccation. Carbapenems, a β-lactam, are the most commonly prescribed drugs against A. baumannii. Resistance against carbapenem has emerged in Acinetobacter baumannii which can create significant health problems and is responsible for high morbidity and mortality. With the development of quantitative proteomics, a considerable progress has been made in the study of carbapenem resistance of Acinetobacter baumannii. Recent updates showed that quantitative proteomics has now emerged as an important tool to understand the carbapenem resistance mechanism in Acinetobacter baumannii. Present review also highlights the complementary nature of different quantitative proteomic methods used to study carbapenem resistance and suggests to combine multiple proteomic methods for understanding the response to antibiotics by Acinetobacter baumannii.
Introduction
Acinetobacter baumannii is one of the six opportunistic pathogens grouped into ESKAPE pathogens that are linked to the highest degree of mortality as described by Infectious Disease Society of America (Klevens et al., 2006; Boucher et al., 2009). It causes pneumonia, urinary tract infections, respiratory infections and meningitis. Acinetobacter baumannii has emerged as a threat to soldiers, wounded during military operations in Iraq and Afghanistan (Davis et al., 2005). The organism can be isolated from natural resources (Kempf et al., 2012). It can grow on artificial surfaces (Espinal et al., 2012) and can utilize ethanol as a carbon source (Navon-Venezia et al., 2005; Fiester and Actis, 2013; Gandhi et al., 2014), resist desiccation, survive at various temperature and pH conditions (Bergogne-Berezin and Towner, 1996), this makes it a lethal pathogen. Prevalence of Acinetobacter baumannii in clinical setup has increased gradually (Tiwari et al., 2012a). Commonly prescribed drug against A. baumannii are carbapenems which belong to the β-lactam group of antibiotics (Hawkey and Jones, 2009). Resistance against carbapenem has emerged in Acinetobacter baumannii which can create significant health problems and responsible for high morbidity and mortality (Sengstock et al., 2010). Reports showed that mortality due to carbapenem-resistant Acinetobacter baumannii is about 52% as compared to 19% when infected with carbapenem sensitive variant (Jamulitrat et al., 2009). This makes it one of the major health concerns.
Quantitative proteomics has been employed for both discovery and targeted proteomic analysis to understand global proteomic dynamics of the organism. With the development of quantitative proteomics, a considerable progress has been made in the study of drug resistance. There are various methods which are used in the quantitative proteomics. Oldest method is the comparison of two commassie stained 2D-PAGE gels (Klose, 1975; O'farrell, 1975; Meleady, 2011; Rabilloud and Lelong, 2011). This was followed by emergence of labeled method like Differential In-Gel Electrophoresis, DIGE (Unlu et al., 1997; Yan et al., 2002; Knowles et al., 2003; Timms and Cramer, 2008), Stable Isotope Labeling by Amino acids in Cell culture, SILAC (Ong et al., 2002; Ong and Mann, 2005) Isotope Coded Affinity Tags, ICAT (Gygi et al., 1999; Gygi and Aebersold, 2000), Isobaric tags quantification, iTRAQ (Ross et al., 2004; Desouza et al., 2009) and Isotope-coded protein label, ICPL (Kellermann, 2008; Abdallah et al., 2012; Kellermann and Lottspeich, 2012). Isotope labels can be introduced into peptides metabolically, chemically or enzymatically. Most recently developed methods for quantitative proteomics are label free quantification methods like spectral counting (Mirza and Olivier, 2008; Zhu et al., 2010) and Selected Reaction Monitoring, SRM (Elschenbroich and Kislinger, 2011; Hossain et al., 2011). In label free proteomic methods, mass spectrometer can recognize the mass difference and their quantification is achieved by comparing their respective signal intensities. Proteomic techniques have been used for the identification and quantification of protein samples and its validation have been done by ELISA (Chen et al., 2010), western blotting (Xiaoyu et al., 2013), immunohistochemistry (Perdomo et al., 2012), RT-PCR and real time PCR (Choi and Shim, 2008; Zhang et al., 2011; Paul et al., 2013; Xiaoyu et al., 2013). In the present review, we critically review the use of quantitative proteomics in the study of carbapenem resistance in Acinetobacter baumannii. We also discuss the future perspective of the quantitative proteomics in the study of carbapenem resistance as well as limitation of different methods used in quantitative proteomics.
Quantitative proteomics as a tool to study of carbapenem resistance in A. baumannii
Quantitative proteomics has very diverse applications and significance but in the present review, we have explained its significance in the study of carbapenem resistance of Acinetobacter baumannii. A number of approaches using quantitative proteomics have been employed for the study of bacterial drug resistance and pathogenesis.
Quantitative outer membrane proteomics between wild type and carbapenem resistance strain of Acinetobacter baumannii have been reported (Marti et al., 2006; Siroy et al., 2006; Kwon et al., 2009). Using silver stained 2DE gel, selection of protein spots based on the intensity and sharpness of the spots in the gel; and identification of the protein by homologous matching with other species of Acinetobacter, Marti et al., performed an analysis of the major proteins in the membrane fraction of a multidrug resistant strain of Acinetobacter baumannii and identify OmpA, ribosomal protein, chaperone and elongation factor (Marti et al., 2006). The result does not highlight the quantitative expression of protein but it signifies the application of the proteomics in the study of carbapenem resistance. Siroy et. al., performed global comparison of the membrane fraction of a sensitive strain with a carbapenem resistant strain of Acinetobacter baumannii by comparing two coomassie stained 2D-PAGE gels. Results highlighted that about 36 and 56% protein spots were different in the inner membrane and outer membrane fraction of resistant strain of Acinetobacter respectively as compared to the sensitive strain (Siroy et al., 2006). They pointed out that resistance against carbapenem has been developed due to overexpression of RND-type efflux systems and virulence factors like FepA-like and siderophore receptors, absence of PBP1b protein, structural modifications to the CarO porin and presence of different isoforms of the channel OmpW in the carbapenem resistant strain of Acinetobacter baumannii (Siroy et al., 2006). This study has given a new direction to the study of carbapenem resistance using quantitative proteomics approach. Similar to approach of Marti et al. (2006), Kwon et al., also used silver stained 2DE gel to identify 132 proteins associated with outer membrane vesicles of Acinetobacter baumannii (Kwon et al., 2009). 2D electrophoresis was also used to explain role of different proteins in metabolism using native ATCC strain of Acinetobacter baumannii (Soares et al., 2009b). Results highlighted that robust and versatile metabolism of Acinetobacter plays very important role in the carbapenem resistance and virulence of A. baumannii (Soares et al., 2009b). Using 2DE based membrane proteomic approach; Lee et al., explained the mechanism of hetero-resistance induced by imipenem (a member of carbapenem group) in the multidrug resistant Acinetobacter baumannii (Lee et al., 2011). They showed that imipenem treatment leads to the up-regulation of AmpC, Cpn60 chaperonin, ATP synthase, and OmpA (Lee et al., 2011).
Vashist et al., showed the importance of outer membrane in the carbapenem resistance using differential DIGE of outer membrane of carbapenem resistance strain as compared to sensitive strain of Acinetobacter (Vashist et al., 2010). They concluded that emergence of carbapenem resistance in A. baumannii is due to the decreased expression of CarO, porins (e.g., Omp-A) and increased expression of biofilm forming protein (e.g., CsuA/B) and nutrient transporters (e.g., iron binding protein, ABC transporter). Vashist et al., identified more proteins with significant role in the carbapenem resistance of Acinetobacter as compare to Siroy et al. (2006), which further confirm the advantages of DIGE based methods (Vashist et al., 2010) over silver stained methods (Siroy et al., 2006). Similarly, Tiwari et al., identified the importance of the metabolism in the carbapenem resistance of Acinetobacter using differential DIGE of inner membrane fraction (Tiwari et al., 2012c). Results concluded that emergence of carbapenem resistance in A. baumannii was found to be associated with overproduction of carbapenem hydrolysing β-lactamase (e.g., AmpC and OXA-51) and metabolic enzymes as well as downregulation of surface antigen and OmpW. They also showed that overproduction of these proteins/enzymes have been achieved by enhanced transcription, translation (e.g., Elongation factor Tu and 30S ribosomal protein) and folding (e.g., 60 KDa chaperonin and TCP-1/cpn60 chaperonin protein (Tiwari et al., 2012c).
Yun et al., performed differential quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii using labeled iTRAQ quantitative approach (Yun et al., 2011). They reported that carbapenem also induces the expression of resistance-nodulation-cell division transporters, protein kinases and suppresses outer membrane proteins expression (Yun et al., 2011). This study further advanced the study of carbapenem resistance of Acinetobacter baumannii because it used isobaric tag for labeling, reverse phase chromatography for peptide separation and MS/MS mass spectrometry for peptide identification which was relatively more sensitive than older methods. They also compared the result from label as well as label free methods and concluded that more than 80% protein have similar expression (down/up-regulation) pattern for label-free (LC-MS/MS) and labeled (iTRAQ) methods (Yun et al., 2011). This result highlighted the importance to use more than one quantitative proteomic method because of their complementary nature to enhance the reproducibility and validity of quantitative proteomic result. The identified proteins from different quantitative proteomic methods have been listed in the Table 1.
Table 1
| Identified Protein | Quantitative Proteomic methods | Significance | ||
|---|---|---|---|---|
| 2DE | DIGE | Isobaric and other | ||
| Carbapenem hydrolyzing beta-lactamase (AmpC and OXA) | Yes | Yes | Yes | Hydrolyze beta-lactams and carbapenem |
| Efflux pumps (AdeABC efflux pump, RND Family transporters) | Yes | Yes | Yes | Aids in the efflux of the antibiotics |
| Penicillin-binding protein (PBP6, PBP1b) | Yes | No | Yes | Synthesis of peptidoglycan, its alteration cause resistance |
| Outer membrane protein (OmpA) | No | Yes | Yes | Associated with non-specific transport |
| CarO protein | Yes | Yes | Yes | Involved in carbapenem resistance |
| Omp W | Yes | Yes | Yes | Down regulation in resistant strains decreases entry of antibiotics |
| Biofilm forming protein (Csu A/B) | Yes | Yes | Yes | CsuA/BABCDE chaperone-usher pili assembly system is require for biofilm formation |
| DcaP like protein | No | Yes | Yes | Associated with cell wall and membrane biogenesis, also have role in biofilm formation |
| Putative porin, OprD family | No | Yes | Yes | Involved in non-specific transport, also have role in biofilm formation |
| Signaling protein (tyrosine kinase) | N/D | N/D | Yes | Involved in novel two-component regulatory system which plays role in biofilm formation |
| Iron-binding protein Receptor (Siderophore receptor) | No | Yes | Yes | Involved in iron transport |
| Chaperonin | No | Yes | Yes | Aids in stress induced stabilization of protein |
| Peptidyl-prolyl cis-trans isomerase | N/D | Yes | Yes | Accelerates the folding of proteins by cis-trans isomerization of proline imidic peptide bonds |
| Regulatory protein (Elongation Factor Tu etc.) | Yes | Yes | Yes | Associated with protein synthesis |
| Energy producing enzymes (MDH, Aconitate hydratase, ATP synthase etc.) | No | Yes | Yes | Associated with energy production in the cell |
| Putative tonB-dependent receptor protein | Yes | N/D | Yes | Acts as TonB-dependent receptor for a non-iron nutrient source |
| ABC transporter | Yes | Yes | Yes | Associated with Phosphate and Amino acid transport |
| Lipoproteins | Yes | Yes | Yes | Involved in the adhesion and translocation of virulence factors in host cells |
| Superoxide dismutase | Yes | Yes | Yes | Destroy free radicals produced in the cell |
| Phosphor-N-acetyl muramoylpentapeptide Transferase | N/D | N/D | Yes | Involved in Cell wall synthesis |
| Cell division protein (zipA) | N/D | N/D | Yes | Involved in cell division |
| Putative universal stress protein family | N/D | N/D | Yes | Involved in the stress response |
Differentially expressed proteins identified in the carbapenem resistance strain as compared to sensitive strain of A. baumannii using various quantitative proteomic approaches (Siroy et al., 2006; Kwon et al., 2009; Vashist et al., 2010; Cabral et al., 2011; Lee et al., 2011; McQueary and Actis, 2011; Yun et al., 2011; Tiwari et al., 2012c).
No, No change; Yes, changed in the resistant strain as compared to sensitive strain; N/D, Not detected.
Pathogenesis of the Acinetobacter is also influenced by host-pathogen interaction and nutritional immunity of the host. Role of nutritional immunity in the survival of carbapenem resistance strain of Acinetobacter in human host has also been studied using differential proteomic approach (Nwugo et al., 2011; Mortensen and Skaar, 2012; Tiwari, 2013). Nwugo et al., compare the 2DE gel of total lysate and outer membrane fractions isolated from A. baumannii sensitive strain cultured under iron-rich and iron-deficient condition. Results indicated that iron-rich condition leads to the overexpression of proteins involved in the iron storage, metabolic process and lipid biosynthesis while iron deficient condition leads to the overexpression of proteins involved in the iron acquisition (Nwugo et al., 2011). Similarly, using DIGE and LC-MS/MS, Tiwari et al., concluded that carbapenem resistant strain of A. baumannii upregulates proteins associated with iron acquisition under iron limiting condition while upregulate metabolic enzymes under iron limiting condition (Tiwari, 2013).
High-end isoelectric point (pH 6–11) differential proteome analysis of Acinetobacter radioresistens also reveals that envelope stress responses can be induced by aromatic compounds (Mazzoli et al., 2011). Role of proteins detected by the quantitative proteomics methods has been validated by other in-vitro or in-vivo methods. It was found that Acinetobacter baumannii develop resistance against carbapenem via alteration in the expression/activity of β-lactamase (Tiwari et al., 2012a,b,c; Tiwari, 2013, 2014; Tiwari and Moganty, 2013, 2014) and alteration in the penicillin binding protein (Vashist et al., 2011). Upregulation of metabolic enzymes/proteins found in the inner membrane protein also enhanced the carbapenem resistance in A. baumannii (Tiwari et al., 2012c).
Biofilm is a functional consortium of microorganisms organized within an extensive exopolymeric matrix (Gurung et al., 2013). Biofilm formation is one of the important causes for the persistence of Acinetobacter baumannii on the surface of host epithelial cells and other surfaces (Espinal et al., 2012; Longo et al., 2014). Cabral et al., performed differential proteomics of Acinetobacter cultured in three different conditions (exponential, late stationary phase and biofilms stage) using 2D-DIGE and MALDI-TOF/TOF as well as iTRAQ/SCX-LC-MS/MS. They also checked the effects of biofilm inhibitory compound (salicylate) on the biofilm formation. This multiple-approach strategy showed a unique lifestyle of A. baumannii involved in biofilm formation (Cabral et al., 2011). CsuA/BABCDE chaperone-usher pili assembly system have been identified in Acinetobacter as essential for biofilm formation on plastic (McQueary and Actis, 2011). OmpA and CarO have role in the uptake of amino acid hence also have role in biofilm formation by Acinetobacter baumannii (Cabral et al., 2011).
Acinetobacter baumannii OMV's induces pathogenesis in the host because of secretion of the outer membrane protein (Kwon et al., 2009) which is cytotoxic to the host (Jin et al., 2011). Secretion of OMVs from A. baumannii has been studied using silver stained 2DE based quantitative proteomics approach (Kwon et al., 2009). Soares et al., identified alterations in the plasma proteome of individuals infected with Acinetobacter baumannii as compared to healthy controls using DIGE based differential proteomic approach (Soares et al., 2009a).
Using quantitative phosphoproteomics approach, selected phosphorylation sites have been identified in Acinetobacter which has been discussed in the context of stress/starvation, pathogenicity and drug resistance (Soares et al., 2014). Qualitative comparison between the Ser/Thr/Tyr phosphoproteomes employed SCX and TiO2 chromatography for enrichment of phosphopeptide and LTQ-Orbitrap mass spectrometric analysis for phosphopeptide identification. The percentage distribution of Ser/Thr/Tyr phosphorylation was found to be 68.9% for serine, 24.1% for threonine and 5.2% for tyrosine in sensitive strain as compared to 70.8% for serine, 25.2% for threonine and 3.8% for tyrosine in carbapenem resistant strain of A. baumannii (Soares et al., 2014). Phosphoproteomics identified 70 phosphoproteins in the multidrug resistant strain (AbH12O-A2) of A. baumannii as compared to 41 phosphoproteins in the sensitive strain (ATCC 17978) of Acinetobacter (Soares et al., 2014). Identified phosphoproteins play role in the pathogenesis (e.g., PtK), virulence (e.g., KdpD/KdpE) and drug resistance (Soares et al., 2014). PtK significantly enhances the ability of Acinetobacter to grow in human biofluids. KdpD/KdpE, a bacterial two-component signal transduction system, have role in the virulence-related regulatory functions (Soares et al., 2014). This study highlight the significance of high throughput quantitative methods for the study of signaling associated with carbapenem resistance strain of Acinetobacter baumannii.
Induction of proteins associated with signaling, putative virulence factors and various stress responses at different stages of in-vitro growth has been identified using growth phase-dependent quantitative proteomics using 2-DE and MALDI-TOF/TOF complemented by iTRAQ and LC-MS/MS (Soares et al., 2010; Fiester and Actis, 2013). This result further highlighted the significance of multiple quantitative approaches used together. Extracellular proteome of Acinetobacter baumannii has been characterized using 2DE and nanoLC-MS/MS based quantitative proteomic approach (Mendez et al., 2012). Mendez et al., used two protein fractions of the extracellular proteome i.e., outer membrane vesicle (OMV) proteins and freely soluble extracellular proteins (FSEPs) present in the culture medium of A. baumannii. The result showed that OMV proteins were found to be associated with pathogenesis and virulence (e.g., CsuE, CsuB, CsuA/B) and secretion systems for delivery of virulence factors while FSEP fraction have extracellular enzymes with degradative activity and role in oxidative stress response (Mendez et al., 2012).
Proteomic experiments also identified differentially expressed lipoproteins as well as proteins responsible for inflammatory/coagulation pathways and kallikrein-kinin system of Acinetobacter which will improve future developments in the pathogenesis of the Acinetobacter and its therapy (Soares et al., 2009a). In quantitative immunoproteomic approach, potentially immunogenic proteins in A. baumannii have been identified using 2DE and MALDI-TOF/TOF mass spectrometric analysis. Immunogenic proteins could serve as antigen for the development of vaccines and passive immunotherapies against A. baumannii infections (Bonin et al., 2014).
Limitation of different quantitative proteomic methods and their significance in the carbapenem resistance studies
There are number of limitations of quantitative proteomic methods that hamper the study of the carbapenem resistance mechanism of Acinetobacter baumannii. Merits and demerit of different methods used in the quantitative proteomics have been listed in the Table 2.
Table 2
| Proteomic Tools | Merits | Demerits | References |
|---|---|---|---|
| GEL-BASED METHODS | |||
| 2DE | (1) Simplistic | (1) Involve large amount of sample | Klose, 1975; O'farrell, 1975; Meleady, 2011; Rabilloud and Lelong, 2011 |
| (2) Robust | (2) Low throughput | ||
| (3) Suitable for MS analysis | (3) Poor recovery of hydrophobic proteins | ||
| (4) High inter-gel variability | |||
| 2D-DIGE | (1) Multiplexing | (1) Expensive Cy dyes | Unlu et al., 1997; Yan et al., 2002; Knowles et al., 2003; Timms and Cramer, 2008; Chen et al., 2010 |
| (2) Better quantitation | (2) Poor recovery of hydrophobic proteins | ||
| (3) Minimized gel to gel variation | (3) Difficulty in separation of low molecular weight | ||
| GEL-FREE METHODS | |||
| SILAC | (1) High throughput | (1) Suitable only for tissue culture models | Ong et al., 2002; Ong and Mann, 2005; Elliott et al., 2009 |
| (2) Robust | (2) Costly reagents | ||
| (3) Sensitive and simple | (3) Not applicable to tissue sample | ||
| ICAT | (1) Selectively isolates peptide | (1) Cannot identify proteins with less than 8 cysteines | Gygi et al., 1999; Gygi and Aebersold, 2000; Toyo'oka, 2012 |
| (2) Compatible with any amount of protein | (2) Size of ICAT label is large (≈500Da) | ||
| (3) Complexity of the peptide mixture is reduced | (3) Post-translational modification information is frequently lost | ||
| iTRAQ | (1) Applicable to versatile samples | (1) Involve high amount of sample | Ross et al., 2004; Desouza et al., 2009 |
| (2) Multiplexing | (2) Incomplete labeling | ||
| (3) Better quantitation | (3) Expensive reagents | ||
| ICPL | (1) High-throughput quantitative proteome profiling on a global scale | (1) Isotopic effect of deuterated tags that interferes with retention time of the labeled peptides during LC | Kellermann, 2008; Abdallah et al., 2012; Kellermann and Lottspeich, 2012 |
| (2) Able to detect post-translational modifications and protein isoforms | |||
| (3) Applicable to protein sample like extracts from tissues or body fluids | |||
| Label-free | (1) Involve less amount of sample | (1) High throughput instrumentation | Mirza and Olivier, 2008; Zhu et al., 2010 |
| (2) Higher proteome coverage | (2) Not suitable for low abundant proteins | ||
| (3) Avoid labeling | (3) Incomplete digestion may introduce error | ||
| (4) Multiplexed analysis is not possible in one experiment | |||
| SRM | (1) Highly sensitive, quantitatively accurate and highly reproducible | (1) Limited broad scale application because of difficulty of generating high-quality SRM assay. | Elschenbroich and Kislinger, 2011; Hossain et al., 2011 |
| (2) Protein detection is relatively rapid and straightforward | (2) Sensitivity is not comparable to immunological assays | ||
| (3) Enable the detection of low (>10 ng/ml) abundance proteins | (3) Detection and quantification of low abundance proteins (i.e., ~ 10 ng/ml or less) | ||
| (4) Quantification of post-translational modification | |||
Different quantitative proteomic approaches with its merits and demerits.
Table 2 showed that most of the methods used in quantitative proteomics did not provide information about post-translational modification and they are unable to detect the small proteins. These two limitations can cost heavily in the studies of carbapenem resistance. Quantitative proteomics is unable to produce all information required to confirm role of protein/biomolecule in carbapenem resistance but it gives global insights about resistance mechanism of Acinetobacter baumannii which helps in the subsequent studies. Quantitative proteomic methods are also unable to give direct confirmation of the role of protein in the carbapenem resistance. Similarly the result of quantitative proteomics is also influenced by protein extraction procedure. These limitations conclude that quantitative proteomics help to a large extent in the study of carbapenem resistance but it requires help of other methods for confirmation. Therefore, we can say that emergence of quantitative proteomics is really an added advantage in the study of carbapenem resistance.
Future perspectives of quantitative proteomics to understand carbapenem resistance
Fluorescence based DIGE methods and isobaric based iTRAQ methods in combination with LC-MS/MS are more popular approach used to study carbapenem resistance mechanism of A. baumannii. Phosphoproteomics and immunoproteomics have also emerged to understand virulence and pathogenesis of carbapenem resistant strain of A. baumannii. Every proteomic method has its own merits and demerits (Table 2) but they provide complementary information. Therefore, combining multiple methods together is an added advantage. This approach has been recently used by some groups to produce valid results (Cabral et al., 2011; Yun et al., 2011). Literature based on proteomic methods has showed the presence of differentially expressed proteins in the carbapenem resistant strain but their actual role in carbapenem resistance has not been confirmed using knockout or auxotroph for resistance factors. Therefore, quantitative proteomic methods also require support from non-proteomic methods. With the development of the quantitative immunoproteomics, phosphoproteomics and other omics methods, the identification of the differentially expressed resistance factors become more reliable. Emergence of quantitative proteomic methods like ICPL and SRM methods will help to remove the shortcoming of the routinely used present methods. Future of quantitative proteomics will depend on the use of two quantitative proteomic methods together with better validation methods to outcome the limitation of the current methods or approach.
Conclusions
The quantitative proteomics has overcome some of the limitations of other approaches for investigating carbapenem resistance. With the development in the quantitative proteomics, new opportunities are now open to study difficult and challenging tasks. Because of complementary nature of different quantitative proteomic methods, it has been suggested to combine multiple quantitative proteomic methods for the better understanding of carbapenem resistance in Acinetobacter baumannii.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Statements
Acknowledgments
Vishvanath Tiwari would like to thanks UGC, India and SERB, DST, India for providing Start-up Grant.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AbdallahC.Dumas-GaudotE.RenautJ.SergeantK. (2012). Gel-based and gel-free quantitative proteomics approaches at a glance. Int. J. Plant Genomics2012:494572. 10.1155/2012/494572
2
Bergogne-BerezinE.TownerK. J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9, 148–165.
3
BoninR. F.ChapeaurougeA.PeralesJ.Da Silva JuniorJ. G.Do NascimentoH. J.D'alincourt Carvalho AssefA. P.et al. (2014). Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach. Proteomics Clin. Appl. 10.1002/prca.201300133. [Epub ahead of print].
4
BoucherH. W.TalbotG. H.BradleyJ. S.EdwardsJ. E.GilbertD.RiceL. B.et al. (2009). Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin. Infect. Dis. 48, 1–12. 10.1086/595011
5
CabralM. P.SoaresN. C.ArandaJ.ParreiraJ. R.RumboC.PozaM.et al. (2011). Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J. Proteome Res. 10, 3399–3417. 10.1021/pr101299j
6
ChenY. T.ChenC. L.ChenH. W.ChungT.WuC. C.ChenC. D.et al. (2010). Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology. J. Proteome Res. 9, 5803–5815. 10.1021/pr100576x
7
ChoiY. E.ShimW. B. (2008). Identification of genes associated with fumonisin biosynthesis in Fusarium verticillioides via proteomics and quantitative real-time PCR. J. Microbiol. Biotechnol. 18, 648–657.
8
DavisK. A.MoranK. A.McAllisterC. K.GrayP. J. (2005). Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerging Infect. Dis. 11, 1218–1224. 10.3201/eid1108.050103
9
DesouzaL. V.RomaschinA. D.ColganT. J.SiuK. W. (2009). Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. Anal. Chem. 81, 3462–3470. 10.1021/ac802726a
10
ElliottM. H.SmithD. S.ParkerC. E.BorchersC. (2009). Current trends in quantitative proteomics. J. Mass Spectrom. 44, 1637–1660. 10.1002/jms.1692
11
ElschenbroichS.KislingerT. (2011). Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol. Biosyst. 7, 292–303. 10.1039/c0mb00159g
12
EspinalP.MartiS.VilaJ. (2012). Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J. Hosp. Infect. 80, 56–60. 10.1016/j.jhin.2011.08.013
13
FiesterS. E.ActisL. A. (2013). Stress responses in the opportunistic pathogen Acinetobacter baumannii. Future Microbiol. 8, 353–365. 10.2217/fmb.12.150
14
GandhiJ. A.EkharV. V.AsplundM. B.AbdulkareemA. F.AhmadiM.CoelhoC.et al. (2014). Alcohol enhances Acinetobacter baumannii-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection. PLoS ONE9:e95707. 10.1371/journal.pone.0095707
15
GurungJ.KhyriemA. B.BanikA.LyngdohW. V.ChoudhuryB.BhattacharyyaP. (2013). Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J. Crit. Care Med. 17, 214–218. 10.4103/0972-5229.118416
16
GygiS. P.AebersoldR. (2000). Mass spectrometry and proteomics. Curr. Opin. Chem. Biol. 4, 489–494. 10.1016/S1367-5931(00)00121-6
17
GygiS. P.RistB.GerberS. A.TurecekF.GelbM. H.AebersoldR. (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994–999. 10.1038/13690
18
HawkeyP. M.JonesA. M. (2009). The changing epidemiology of resistance. J. Antimicrob. Chemother. 64Suppl. 1, i3–10. 10.1093/jac/dkp256
19
HossainM.KaletaD. T.RobinsonE. W.LiuT.ZhaoR.PageJ. S.et al. (2011). Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface. Mol. Cell Proteomics10, M000062–MCP000201. 10.1074/mcp.M000062-MCP201
20
JamulitratS.ArunpanP.PhainuphongP. (2009). Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J. Med. Assoc. Thai. 92, 413–419.
21
JinJ. S.KwonS. O.MoonD. C.GurungM.LeeJ. H.KimS. I.et al. (2011). Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS ONE6:e17027. 10.1371/journal.pone.0017027
22
KellermannJ. (2008). ICPL—isotope-coded protein label. Methods Mol. Biol. 424, 113–123. 10.1007/978-1-60327-064-9_10
23
KellermannJ.LottspeichF. (2012). Isotope-coded protein label. Methods Mol. Biol. 893, 143–153. 10.1007/978-1-61779-885-6_11
24
KempfM.BakourS.FlaudropsC.BerrazegM.BrunelJ. M.DrissiM.et al. (2012). Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS ONE7:e31676. 10.1371/journal.pone.0031676
25
KlevensR. M.EdwardsJ. R.TenoverF. C.McDonaldL. C.HoranT.GaynesR.et al. (2006). Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clin. Infect. Dis. 42, 389–391. 10.1086/499367
26
KloseJ. (1975). Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik26, 231–243.
27
KnowlesM. R.CervinoS.SkynnerH. A.HuntS. P.De FelipeC.SalimK.et al. (2003). Multiplex proteomic analysis by two-dimensional differential in-gel electrophoresis. Proteomics3, 1162–1171. 10.1002/pmic.200300437
28
KwonS. O.GhoY. S.LeeJ. C.KimS. I. (2009). Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol. Lett. 297, 150–156. 10.1111/j.1574-6968.2009.01669.x
29
LeeH. Y.ChenC. L.WangS. B.SuL. H.ChenS. H.LiuS. Y.et al. (2011). Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int. J. Antimicrob. Agents37, 302–308. 10.1016/j.ijantimicag.2010.12.015
30
LongoF.VuottoC.DonelliG. (2014). Biofilm formation in Acinetobacter baumannii. New Microbiol. 37, 119–127.
31
MartiS.Sanchez-CespedesJ.OliveiraE.BellidoD.GiraltE.VilaJ. (2006). Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii. Proteomics6Suppl. 1, S82–S87. 10.1002/pmic.200500323
32
MazzoliR.FattoriP.LambertiC.GiuffridaM. G.ZapponiM.GiuntaC.et al. (2011). High isoelectric point sub-proteome analysis of Acinetobacter radioresistens S13 reveals envelope stress responses induced by aromatic compounds. Mol. Biosyst. 7, 598–607. 10.1039/c0mb00112k
33
McQuearyC. N.ActisL. A. (2011). Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties. J. Microbiol. 49, 243–250. 10.1007/s12275-011-0343-7
34
MeleadyP. (2011). 2D gel electrophoresis and mass spectrometry identification and analysis of proteins. Methods Mol. Biol. 784, 123–137. 10.1007/978-1-61779-289-2_9
35
MendezJ. A.SoaresN. C.MateosJ.GayosoC.RumboC.ArandaJ.et al. (2012). Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii. J. Proteome Res. 11, 5678–5694. 10.1021/pr300496c
36
MirzaS. P.OlivierM. (2008). Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry. Physiol. Genomics33, 3–11. 10.1152/physiolgenomics.00292.2007
37
MortensenB. L.SkaarE. P. (2012). Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell. Microbiol. 14, 1336–1344. 10.1111/j.1462-5822.2012.01817.x
38
Navon-VeneziaS.Ben-AmiR.CarmeliY. (2005). Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr. Opin. Infect. Dis. 18, 306–313. 10.1097/01.qco.0000171920.44809.f0
39
NwugoC. C.GaddyJ. A.ZimblerD. L.ActisL. A. (2011). Deciphering the iron response in Acinetobacter baumannii: a proteomics approach. J. Proteomics74, 44–58. 10.1016/j.jprot.2010.07.010
40
O'farrellP. H. (1975). High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007–4021.
41
OngS. E.BlagoevB.KratchmarovaI.KristensenD. B.SteenH.PandeyA.et al. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics1, 376–386. 10.1074/mcp.M200025-MCP200
42
OngS. E.MannM. (2005). Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1, 252–262. 10.1038/nchembio736
43
PaulD.KumarA.GajbhiyeA.SantraM. K.SrikanthR. (2013). Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res. Int. 2013, 783131. 10.1155/2013/783131
44
PerdomoA. B.CiccosantiF.IaconoO. L.AngelettiC.CorazzariM.DanieleN.et al. (2012). Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome. J. Proteome Res. 11, 717–727. 10.1021/pr2006445
45
RabilloudT.LelongC. (2011). Two-dimensional gel electrophoresis in proteomics: a tutorial. J. Proteomics74, 1829–1841. 10.1016/j.jprot.2011.05.040
46
RossP. L.HuangY. N.MarcheseJ. N.WilliamsonB.ParkerK.HattanS.et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics3, 1154–1169. 10.1074/mcp.M400129-MCP200
47
SengstockD. M.ThyagarajanR.ApalaraJ.MiraA.ChopraT.KayeK. S. (2010). Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin. Infect. Dis. 50, 1611–1616. 10.1086/652759
48
SiroyA.CosetteP.SeyerD.Lemaitre-GuillierC.VallenetD.Van DorsselaerA.et al. (2006). Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain. J. Proteome Res. 5, 3385–3398. 10.1021/pr060372s
49
SoaresA. J.SantosM. F.TrugilhoM. R.Neves-FerreiraA. G.PeralesJ.DomontG. B. (2009a). Differential proteomics of the plasma of individuals with sepsis caused by Acinetobacter baumannii. J. Proteomics73, 267–278. 10.1016/j.jprot.2009.09.010
50
SoaresN. C.CabralM. P.GayosoC.MalloS.Rodriguez-VeloP.Fernandez-MoreiraE.et al. (2010). Associating growth-phase-related changes in the proteome of Acinetobacter baumannii with increased resistance to oxidative stress. J. Proteome Res. 9, 1951–1964. 10.1021/pr901116r
51
SoaresN. C.CabralM. P.ParreiraJ. R.GayosoC.BarbaM. J.BouG. (2009b). 2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism. Proteome Sci. 7, 37. 10.1186/1477-5956-7-37
52
SoaresN. C.SpatP.MendezJ. A.NakediK.ArandaJ.BouG. (2014). Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate. J. Proteomics102, 113–124. 10.1016/j.jprot.2014.03.009
53
TimmsJ. F.CramerR. (2008). Difference gel electrophoresis. Proteomics8, 4886–4897. 10.1002/pmic.200800298
54
TiwariV. (2013). Effect of iron availability on the survival of carbapenem-resistant Acinetobacter baumannii: a proteomic approach. J. Proteomics Bioinform. 6, 125–131. 10.4172/jpb.1000270
55
TiwariV. (2014). Membrane Proteomics has emerged as a tool to study carbapenem resistance in Acinetobacter baumannii. J. Proteomics Bioinform. 7:e2610.4172/jpb.10000e26
56
TiwariV.KapilA.MogantyR. R. (2012a). Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microb. Pathog. 53, 81–86. 10.1016/j.micpath.2012.05.004
57
TiwariV.MogantyR. R. (2013). Structural studies on New Delhi Metallo-β-lactamase (NDM-2) suggest old β-lactam, penicillin to be better antibiotic for NDM-2-harbouring Acinetobacter baumanni. J. Biomol. Struct. Dyn. 31, 591–601. 10.1080/07391102.2012.706075
58
TiwariV.MogantyR. R. (2014). Conformational stability of OXA-51 β-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii. J. Biomol. Struct. Dyn. 32, 1406–1420. 10.1080/07391102.2013.819789
59
TiwariV.NagpalI.SubbaraoN.MogantyR. R. (2012b). In-silico modeling of a novel OXA-51 from beta-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics. J. Mol. Model. 18, 3351–3361. 10.1007/s00894-011-1346-3
60
TiwariV.VashisttJ.KapilA.MogantyR. R. (2012c). Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS ONE7:e39451. 10.1371/journal.pone.0039451
61
Toyo'okaT. (2012). LC-MS determination of bioactive molecules based upon stable isotope-coded derivatization method. J. Pharm. Biomed. Anal. 69, 174–184. 10.1016/j.jpba.2012.04.018
62
UnluM.MorganM. E.MindenJ. S. (1997). Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis18, 2071–2077. 10.1002/elps.1150181133
63
VashistJ.TiwariV.DasR.KapilA.RajeswariM. R. (2011). Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. Indian J. Med. Res. 133, 332–338.
64
VashistJ.TiwariV.KapilA.RajeswariM. R. (2010). Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii. J. Proteome Res. 9, 1121–1128. 10.1021/pr9011188
65
XiaoyuL.WeiyuanZ.PingJ.AnxiaW.LianeZ. (2013). Comparative serum proteomic analysis of adenomyosis using the isobaric tags for relative and absolute quantitation technique. Fertil. Steril. 100, 505–510. 10.1016/j.fertnstert.2013.04.008
66
YanJ. X.DevenishA. T.WaitR.StoneT.LewisS.FowlerS. (2002). Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics2, 1682–1698. 10.1002/1615-9861(200212)2:12<1682::AID-PROT1682>3.0.CO;2-Y
67
YunS. H.ChoiC. W.KwonS. O.ParkG. W.ChoK.KwonK. H.et al. (2011). Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J. Proteome Res. 10, 459–469. 10.1021/pr101012s
68
ZhangJ.SongM. Q.ZhuJ. S.ZhouZ.XuZ. P.ChenW. X.et al. (2011). Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry. Int. J. Immunopathol. Pharmacol. 24, 849–859.
69
ZhuW.SmithJ. W.HuangC. M. (2010). Mass spectrometry-based label-free quantitative proteomics. J. Biomed. Biotechnol. 2010, 840518. 10.1155/2010/840518
Summary
Keywords
quantitative proteomics, Acinetobacter baumannii, carbapenem resistance, pathogenesis, biofilm formation
Citation
Tiwari V and Tiwari M (2014) Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii. Front. Microbiol. 5:512. doi: 10.3389/fmicb.2014.00512
Received
25 June 2014
Accepted
11 September 2014
Published
26 September 2014
Volume
5 - 2014
Edited by
Ana Cristina Esteves, University of Aveiro, Portugal
Reviewed by
Benjamin Andrew Evans, Anglia Ruskin University, UK; Bart Devreese, Ghent University, Belgium
Copyright
© 2014 Tiwari and Tiwari.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vishvanath Tiwari, Department of Biochemistry, Central University of Rajasthan, Ajmer, Rajasthan 305817, India e-mail: vishvanath7@yahoo.co.in
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.